Difference between revisions of "Nanobiosym"
Liaton9000 (talk | contribs) (Added People section.) |
Liaton9000 (talk | contribs) (Added additional reference for Robert Langer and Moderna.) |
||
(One intermediate revision by the same user not shown) | |||
Line 46: | Line 46: | ||
Nanobiosym was founded by [[Anita Goel]], who serves as Chairman and CEO. Goel is an advisor to the [[Taksha Institute]], [[Lockheed Martin]] and the [[President's Council of Advisors on Science and Technology]] (PCAST), and served on the [[National Academy of Engineering]]'s Committee on Manufacturing, Design, and Innovation. She also serves on the [[Canadian Institute for Advanced Research]] (CIFAR) research council, is a fellow of the [[World Technology Network]], a fellow-at-large of the [[Santa Fe Institute]], an Adjunct Professor at the [[Beyond Center for Fundamental Concepts in Physics]], and an associate of the [[Harvard Department of Physics]].<ref>''Anita Goel, MD, PhD.'' Taksha Institute. Retrieved November 27, 2023, from http://archive.today/2023.11.27-053732/https://www.taksha.org/advisors/goel/</ref> | Nanobiosym was founded by [[Anita Goel]], who serves as Chairman and CEO. Goel is an advisor to the [[Taksha Institute]], [[Lockheed Martin]] and the [[President's Council of Advisors on Science and Technology]] (PCAST), and served on the [[National Academy of Engineering]]'s Committee on Manufacturing, Design, and Innovation. She also serves on the [[Canadian Institute for Advanced Research]] (CIFAR) research council, is a fellow of the [[World Technology Network]], a fellow-at-large of the [[Santa Fe Institute]], an Adjunct Professor at the [[Beyond Center for Fundamental Concepts in Physics]], and an associate of the [[Harvard Department of Physics]].<ref>''Anita Goel, MD, PhD.'' Taksha Institute. Retrieved November 27, 2023, from http://archive.today/2023.11.27-053732/https://www.taksha.org/advisors/goel/</ref> | ||
+ | |||
+ | Nanobiosym's board of advisors includes numerous influential individuals.<ref>''Team.'' Nanobiosym. Retrieved November 27, 2023, from http://archive.today/2023.11.27-044333/https://nanobiosym.com/our-team/</ref> This includes [[Robert Langer]], professor at the [[Massachusetts Institute of Technology]] (MIT) and co-founder of [[Moderna]],<ref>Elton, C. (2013, February 26). ''Does Moderna Therapeutics Have the Next Big Thing in Medicine?'' Boston Magazine. https://web.archive.org/web/20230606065355/https://www.bostonmagazine.com/health/2013/02/26/moderna-therapeutics-new-medical-technology/</ref> and [[Ratan Tata]], chairman of [[Tata Sons]] and advisor to [[JPMorgan Chase]], the [[Bill & Melinda Gates Foundation]]'s India AIDS Initiative and the [[Government of India]]. | ||
===Investors=== | ===Investors=== |
Latest revision as of 17:25, 23 May 2024
Nanobiosym (Big pharma) | |
---|---|
Formation | 2002 |
Founder | Anita Goel |
Headquarters | Massachusetts, USA |
Type | • Genetics • nanotechnology |
Slogan | Where little things make a big difference |
Membership | • Alfred Ford • Robert Langer • David Lopez • John Palmer • Paul Maritz • Ratan Tata • John Abele • Tenley Albright • Tarun Khama • Homi Mullan |
American nanotechnology company |
Nanobiosym, formerly called Nanotune, is an American nanotechnology company based in Cambridge, Massachusetts.
History
Nanotune, Inc. was incorporated in Delaware on January 10, 2002.[1] The company received $448,844 in funding in 2004 from the Air Force Office of Scientific Research for research on "biomolecular motors (biomotors)".[2] On November 4, 2004, Nanotune changed its name to Nanobiosym.[3]
Nanobiosym Diagnostics was incorporated in Delaware on February 27, 2006.[4] On September 26, 2007, Nanobiosym announced that it and Nanobiosym Diagnostics had received a $2 million contract from the Defense Threat Reduction Agency (DTRA) to support the development of its Gene-RADAR genetic test, "a portable nanotechnology-enabled platform, that can rapidly and accurately detect genetic fingerprints from any biological organism." The funding was described by Nanobiosym founder Anita Goel as "our first defense contract" and "a major step towards establishing the US government as one of our long-term customers."[5]
A branch of Nanobiosym Diagnostics was incorporated in Massachusetts on December 19, 2008.[6]
Nanobiosym Advisory Services LLC was incorporated on July 20, 2012.[7]
At the annual meeting of the Clinton Global Initiative on September 30, 2015, Nanobiosym chairman Anita Goel announced the company's intention to deploy its Gene-RADAR genetic test "in Africa to stop Ebola and other infectious outbreaks."[8]
COVID-19
Nanobiosym paid $90,000 in 2020 to Ballard Partners' Brian Ballard and Dan Mcfaul to lobby the White House, the United States Department of Health and Human Services and the Overseas Private Investment Corporation on issues related to health and pharmaceuticals.[9]
On November 8, 2022, Nanobiosym received an Emergency Use Authorization (EUA) for a SARS-CoV-2 polymerase chain reaction (PCR) test called "The Nano Test for COVID-19".[10]
Organization
Nanobiosym's subsidiaries include Nanobiosym Diagnostics, Nanobiosym Education and Research Institute (NERI), Nanobiosym Global Initiative, and Nanobiosym Precision Testing Services.
People
Nanobiosym was founded by Anita Goel, who serves as Chairman and CEO. Goel is an advisor to the Taksha Institute, Lockheed Martin and the President's Council of Advisors on Science and Technology (PCAST), and served on the National Academy of Engineering's Committee on Manufacturing, Design, and Innovation. She also serves on the Canadian Institute for Advanced Research (CIFAR) research council, is a fellow of the World Technology Network, a fellow-at-large of the Santa Fe Institute, an Adjunct Professor at the Beyond Center for Fundamental Concepts in Physics, and an associate of the Harvard Department of Physics.[11]
Nanobiosym's board of advisors includes numerous influential individuals.[12] This includes Robert Langer, professor at the Massachusetts Institute of Technology (MIT) and co-founder of Moderna,[13] and Ratan Tata, chairman of Tata Sons and advisor to JPMorgan Chase, the Bill & Melinda Gates Foundation's India AIDS Initiative and the Government of India.
Investors
Investors in Nanobiosym include:[14]
- Crown Holdings
- David Lopez[15]
- Integro Capital
- Massachusetts Life Sciences Center
- Mission Growth Investments[16]
- Paul Maritz
- Unreasonable Group[17]
Nanobiosym has also received funding through grants and government contracts from:
- Air Force Office of Scientific Research (AFOSR)
- Defense Advanced Research Projects Agency (DARPA)
- Defense Threat Reduction Agency (DTRA)
- United States Department of Energy (DOE)
Lobbying
Lobbying firms hired by Nanobiosym include:
- Ballard Partners
- Capitol Hill Consulting Group[18]
- Cornerstone Government Affairs[19]
- K&L Gates[20]
- Podesta Group[21]
- Wiley Rein
References
- ↑ Delaware Department of State, Division of Corporations. (2019, August 31). Nanobiosym, Inc. OpenCorporates. https://opencorporates.com/companies/us_de/3477641
- ↑ 2004 DARPA Funding List. Executive Services Directorate. Retrieved February 13, 2024, from https://web.archive.org/web/20240213030308/https://www.esd.whs.mil/Portals/54/Documents/FOID/Reading%20Room/Science_and_Technology/12-F-1039_2004-DARPA-Funding-List.pdf
- ↑ Business Entity Summary - NANOBIOSYM, INC. Secretary of the Commonwealth of Massachusetts, Corporations Division. Retrieved February 13, 2024, from http://archive.today/2024.02.13-030048/https://corp.sec.state.ma.us/CorpWeb/CorpSearch/CorpSummary.aspx?sysvalue=tdckOJujVyIWJkN0yNBHllZ5GyHXxEQt6Kyz0tqy2uk-
- ↑ Delaware Department of State: Division of Corporations. (2019, August 31). Nanobiosym Diagnostics, Inc. OpenCorporates. https://opencorporates.com/companies/us_de/4116076
- ↑ Bagwadia, Z. (2007, September 26). Press Release: Nanobiosym Awarded $2M Contract From U.S. Defense Threat Reduction Agency (DTRA). Nanotechnology Now. http://archive.today/2024.05.07-205708/https://www.nanotech-now.com/news.cgi?story_id=25215
- ↑ Massachusetts Secretary of the Commonwealth, Corporations Division. (2024, February 5). Nanobiosym Diagnostics, Inc. OpenCorporates. https://opencorporates.com/companies/us_ma/000992043
- ↑ Massachusetts Secretary of the Commonwealth, Corporations Division. (2024, February 5). Nanobiosym Advisory Services LLC. OpenCorporates. https://opencorporates.com/companies/us_ma/462735849
- ↑ Webb, J. (2015, September 30). Nanobiosym’s Gene-RADAR® Unveiled as the “Next Frontier” in Healthcare Technology at the Clinton Global Initiative Annual Meeting. Business Wire. http://archive.today/2024.01.03-201152/https://www.businesswire.com/news/home/20150928006575/en/Nanobiosyms-Gene-RADAR®-Unveiled-as-the-‘Next-Frontier’-in-Healthcare-Technology-at-the-Clinton-Global-Initiative-Annual-Meeting
- ↑ Nanobiosym Diagnostics Lobbying Profile. (2023, July 24). OpenSecrets. https://www.opensecrets.org/federal-lobbying/clients/summary?cycle=2020&id=F307211
- ↑ The Nano Test for COVID-19 EUA Summary. (2022, November 8). Food and Drug Administration. https://web.archive.org/web/20230511163446/https://www.fda.gov/media/163098/download#:~:text=The%20Nano%20Test%20for%20COVID%2D19%20is%20a%20real%2Dtime,Nano%2DSaliva%20Collection%20Kit%2C%20when
- ↑ Anita Goel, MD, PhD. Taksha Institute. Retrieved November 27, 2023, from http://archive.today/2023.11.27-053732/https://www.taksha.org/advisors/goel/
- ↑ Team. Nanobiosym. Retrieved November 27, 2023, from http://archive.today/2023.11.27-044333/https://nanobiosym.com/our-team/
- ↑ Elton, C. (2013, February 26). Does Moderna Therapeutics Have the Next Big Thing in Medicine? Boston Magazine. https://web.archive.org/web/20230606065355/https://www.bostonmagazine.com/health/2013/02/26/moderna-therapeutics-new-medical-technology/
- ↑ Nanobiosym Company Profile: Valuation & Investors. PitchBook. Retrieved August 26, 2023, from http://archive.today/2023.08.27-062516/https://pitchbook.com/profiles/company/109455-31%23comparisons
- ↑ Experience | Dave Lopez. LinkedIn. Retrieved July 19, 2023, from http://archive.today/2023.07.19-225940/https://www.linkedin.com/in/dave-lopez-7b2306193/details/experience/
- ↑ Nanobiosym. Tracxn. Retrieved August 27, 2023, from https://web.archive.org/web/20230827063851/https://tracxn.com/d/companies/nanobiosym/__M-7FbYsfk7_1TLvf4Lcn_XBP301Qg_AGvsX32hsouXY
- ↑ Nanobiosym – an Unreasonable company. Unreasonable Group. Retrieved August 27, 2023, from https://web.archive.org/web/20230827061727/https://unreasonablegroup.com/ventures/nanobiosym
- ↑ Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 29, 2023, from https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2021&id=D000054092
- ↑ Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 30, 2023, from https://web.archive.org/web/20230830021621/https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2015&id=D000054092
- ↑ Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 30, 2023, from https://web.archive.org/web/20230830021815/https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2009&id=D000054092
- ↑ Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 30, 2023, from http://archive.today/2023.08.30-021138/https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2016&id=D000054092